Sensorion announces a poster presentation of new SENS-401 preclinical data at SFN 2019 in Chicago. pdfRead

Sensorion announces the last patient’s last visit in SENS-111 Phase 2 clinical trial. pdfRead

Sensorion completes a capital increase of €18.1 million subscribed by leading biotech investors. pdfRead

Sensorion announces two presentations at AAO-HNSF 2019 in New Orleans. pdfread

Sensorion announces three presentations at IEB 2019 in Padua. pdfRead